Clinical trial
Leuprolide in Determining the Cause of Gonadotropin Deficiency
NCT00004426 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00004426 |
|---|---|
| Title | Leuprolide in Determining the Cause of Gonadotropin Deficiency |
| Official title | Study of Gonadotropin Releasing Hormone Agonist Test Using Leuprolide Acetate in Patients With Gonadotropin Deficiency |
| Lead sponsor | University of Chicago, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypogonadism |
| Intervention type | Drug |
| Interventions | gonadotropin releasing hormone, leuprolide |
| Enrollment | 90 |
| Start date | Aug 1, 1994 |
| Completion | Sep 1, 1998 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 26, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: